Iress (IRE) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
27 Apr, 2026Opening remarks and agenda
Meeting opened by the Chair, acknowledging traditional land owners and introducing directors and leadership team, with addresses from the Chair and Group CEO.
Agenda included review of financial statements, director reappointments, remuneration report, grant of share appreciation rights, general questions, and voting finalisation.
Voting procedures and Q&A processes for both in-person and online attendees were outlined.
Financial performance review
Statutory net profit after tax reached AUD 79.3 million, with underlying profit after tax (UPAT) up 16.6% to AUD 73.9 million.
Revenue from continuing business increased 6.5% to AUD 504.3 million; adjusted EBITDA up 14.9% to AUD 132.6 million.
FY25 headline results exceeded guidance, with Adjusted EBITDA at AUD 136.2 million.
Asset sales strengthened the balance sheet, reducing group leverage from 1x to 0.5x.
FY26 guidance projects revenue of AUD 520–528 million, Cash EBITDA of AUD 116–123 million, and UPAT of AUD 84–90 million.
Board and executive committee updates
Leadership transition saw Andrew Russell appointed as Group CEO and MD in November 2025.
Board renewal continued, with eight directors leaving and six new appointments over five years; average tenure now 3.5 years.
Board comprises a mix of non-executive directors and committee chairs.
Recruitment underway for an additional director with deep software expertise.
Latest events from Iress
- FY25 outperformed guidance with strong revenue, margin expansion, and robust FY26 growth outlook.IRE
H2 20259 Apr 2026 - Record results, margin expansion, and strong FY25 growth guidance after transformation.IRE
H2 20243 Apr 2026 - Adjusted EBITDA up 52% and margin expansion drive upgraded guidance and dividend return.IRE
H1 20241 Feb 2026 - Strong FY24 results, board renewal, and decisive support for all resolutions.IRE
AGM 202528 Nov 2025 - EPS up 19.2%, revenue up 6.8%, leverage at 0.8x, interim dividend 11.0cps.IRE
H1 202523 Nov 2025